• Profile
Close

Short-term adherence marker to PrEP predicts future nonretention in a large PrEP demo project: Implications for point-of-care adherence testing

Journal of Acquired Immune Deficiency Syndromes May 23, 2019

Spinelli MA, et al. - Researchers conducted secondary data analysis of a large, prospective multi-site US PrEP demonstration project to investigate if measures of short-term and long-term PrEP adherence could be related to future study nonretention using an adjusted Cox-proportional hazards model. Within the US PrEP demonstration project, 294 individuals (median age 33 years) contributed drug levels, used to assess adherence. Observations revealed a strong association of both short- and long-term metrics of PrEP adherence with the future loss to follow-up in a US demonstration project study. They noted utility of short-term metrics of adherence, once available at the point-of-care, to direct real-time tailored retention and adherence interventions.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay